PILL.CN Stock - Canntab Therapeutics Limited
Unlock GoAI Insights for PILL.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $293,362 | N/A | $133,334 | $240,000 | $26,667 |
| Gross Profit | $69,468 | $-546,000 | $133,334 | $143,614 | $26,667 |
| Gross Margin | 23.7% | N/A | 100.0% | 59.8% | 100.0% |
| Operating Income | $-4,606,000 | $-3,761,000 | $-2,616,000 | $-2,502,000 | $-1,554,000 |
| Net Income | $-3,689,000 | $-4,609,000 | $-2,607,000 | $-2,459,000 | $-2,408,000 |
| Net Margin | -1257.5% | N/A | -1955.2% | -1024.6% | -9029.9% |
| EPS | $-0.10 | $-0.13 | $-0.10 | $-0.10 | $-0.11 |
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Visit WebsiteEarnings History & Surprises
PILL.CNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2023 | Feb 28, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 30, 2022 | — | $-0.03 | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.04 | — | — |
Q1 2022 | Feb 28, 2022 | — | $0.00 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.03 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.02 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.06 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.02 | — | — |
Q4 2020 | Nov 30, 2020 | — | $-0.02 | — | — |
Q3 2020 | Aug 31, 2020 | — | $-0.03 | — | — |
Q2 2020 | May 31, 2020 | — | $-0.03 | — | — |
Q1 2020 | Feb 29, 2020 | — | $-0.03 | — | — |
Q4 2019 | Nov 30, 2019 | — | $-0.02 | — | — |
Q3 2019 | Aug 31, 2019 | — | $-0.02 | — | — |
Q2 2019 | May 31, 2019 | — | $-0.02 | — | — |
Q1 2019 | Feb 28, 2019 | — | $-0.03 | — | — |
Q4 2018 | Nov 30, 2018 | — | $-0.03 | — | — |
Q3 2018 | Aug 31, 2018 | — | $-0.02 | — | — |
Q2 2018 | May 31, 2018 | — | $-0.07 | — | — |
Latest News
Frequently Asked Questions about PILL.CN
What is PILL.CN's current stock price?
What is the analyst price target for PILL.CN?
What sector is Canntab Therapeutics Limited in?
What is PILL.CN's market cap?
Does PILL.CN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PILL.CN for comparison